Sulforaphane Synergizes With PD‐1 Blockade Through Activating CD8 + T Cells in Non–Small Cell Lung Cancer: Preclinical and Clinical Investigations

Documenti analoghi

• Improvement of the Anticancer Efficacy of PD‐1/PD‐L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies
  di: Peng Gao, et al.
  Pubblicazione: (2025)
• Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity
  di: Xiangxin Geng, et al.
  Pubblicazione: (2025)
• Peripheral Blood Mononuclear Cells Profiling Revealed Biomarkers That Predict PD‐1 Inhibitor‐Induced Immune‐Related Adverse Events
  di: Jun Wang, et al.
  Pubblicazione: (2026)
• Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
  di: Yaqing Liu, et al.
  Pubblicazione: (2025)
• Cancer Stem Cells in Human Gastrointestinal and Hepatic Cancers
  di: Jiawen Bu, et al.
  Pubblicazione: (2025)